AZD1208 is a novel, orally bioavailable, highly selective PIM kinases inhibitor with single nanomolar potency against all three PIM kinases and is currently undergoing Phase I testing and dose escalation studies in AML.

June 21, 2017

prudect name : AZD1208 is a novel, orally bioavailable, highly selective PIM kinases inhibitor with single nanomolar potency against all three PIM kinases and is currently undergoing Phase I testing and dose escalation studies in AML.
AZD1208

Synonyms: CAS NO: 1204144-28-4Molecular Formula: C₂₁H₂₁N₃O₂SMolecular Weight: 379.48Purity: 98% minSolubility: in DMSOStorage: -20oC

1380288-87-8 References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18502225